About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Slc7a11tm1Hsat
targeted mutation 1, Hideyo Sato
MGI:3608695
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Slc7a11tm1Hsat/Slc7a11tm1Hsat involves: 129P2/OlaHsd * C57BL/6 MGI:3608978


Genotype
MGI:3608978
hm1
Allelic
Composition
Slc7a11tm1Hsat/Slc7a11tm1Hsat
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc7a11tm1Hsat mutation (0 available); any Slc7a11 mutation (49 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• plasma GSH levels are reduced to about 1/2 wild-type and total non-protein-bound disulfide forms of GSH are increased; however GSH content of the liver, kidney, cerebrum, cerebellum, thymus, and spleen are all similar to wild-type
• plasma levels of cystine are increased about 2-fold whereas plasma cysteine concentration is similar to that in controls
• plasma concentration of the total non-protein-bound disulfide forms of cysteine is much higher than in controls

cellular
• homozygous embryonic fibroblasts die in culture unless supplemented with 50uM 2-mercaptoethanol, more than 1mM N-acetyl cysteine, or vitamin E (protects from death but does not support proliferation)
• homozygous embryonic fibroblasts fail to proliferate in culture unless supplemented with 50uM 2-mercaptoethanol or more than 1mM N-acetyl cysteine





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory